Positron emission tomography (PET) for alzheimer's disease (AD)
HAYES, Inc.
Record ID 32008000035
English
Authors' objectives:
Positron emission tomography (PET) is a three-dimensional (3D) nuclear imaging technique that measures the level of physiologic and biochemical activity or other organic function in an organ or tissue by reflecting the distribution of a radiotracer that has been administered to the patient. PET has been proposed as a method for diagnosing and predicting Alzheimer-s disease (AD) and for monitoring and predicting response to treatment for AD.
Authors' methods:
Review
Details
Project Status:
Completed
Year Published:
2007
URL for published report:
This report has been updated. The current report can be purchased from: http://www.hayesinc.com/hayes/crd/?crd=2056
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Alzheimer Disease
- Positron-Emission Tomography
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2007 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.